Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acipimox for Mitochondrial Function in Obesity
NCT01488409Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- May 2012
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acipimox in obesity, insulin resistance (IR), sponsored by Massachusetts General Hospital. Started May 2012; status: completed.
02
Drugs
acipimox
03
Conditions
obesityinsulin resistance (IR)
Beyond the preview
Go deeper on NCT01488409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01488409.